Company Name: Sophiris Bio, Inc.
Sophiris Bio Inc. is a biopharmaceutical company. The company is engaged in the development of PRX302 (topsalysin), a targeted therapy for urological diseases (in development for the treatment of the symptoms of BPH).
Ticker Symbol: SPHS (NASDAQ)
Company Website: www.sophirisbio.com
Social Media: Sophiris Bio LinkedIn
Headquarters: La Jolla, CA